SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): April 8, 2013 (April 5, 2013)

 

Neuralstem, Inc.

(Exact name of registrant as specified in Charter)

 

 

Delaware 000-1357459  

52-2007292

(State or other jurisdiction of

incorporation or organization)

   (Commission File No.)   (IRS Employee Identification No.)

 

9700 Great Seneca Highway, Rockville, Maryland 20850

(Address of Principal Executive Offices)

 

(301) 366-4841

(Issuer Telephone number)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 8.01.Other Events.

 

On April 5, 2013, Neuralstem, Inc. (“Company”) announced that it received a notice of allowance for patent application 12/404,841. A copy of the press release is attached to this report as Exhibit 99.01.

 

 

Item 9.01Financial Statement and Exhibits.

  

Exhibit Number

   Description 
     
99.01   Press Release Dated April 5, 2013
     
     
     
     

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Issuer has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

  NEURALSTEM, INC  
         
  By:  

/s/ I. Richard Garr

  
     

I. Richard Garr

Chief Executive Officer

  

 

Dated: April 8, 2013